Found 69 Enz. Inhib. hit(s) with Target = 'Adenosine receptor A3 [I248L]' TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.90nM ΔG°: -47.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 6.60nM ΔG°: -46.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.90nM ΔG°: -46.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10.3nM ΔG°: -45.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 12nM ΔG°: -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 12.1nM ΔG°: -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 15.2nM ΔG°: -44.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 16.5nM ΔG°: -44.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 32.4nM ΔG°: -42.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 40.4nM ΔG°: -42.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 41.5nM ΔG°: -42.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 52nM ΔG°: -41.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 83.2nM ΔG°: -40.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 110nM ΔG°: -39.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 114nM ΔG°: -39.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 160nM ΔG°: -38.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 236nM ΔG°: -37.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 315nM ΔG°: -37.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 470nM ΔG°: -36.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 500nM ΔG°: -36.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 560nM ΔG°: -35.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 797nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.53E+3nM ΔG°: -33.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.97E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.69E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.81E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.10E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.15E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.16E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.64E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.89E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.67E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.68E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.86E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 6.00E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.11E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.90E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.35E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.39E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.97E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.98E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 9.01E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 9.25E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.01E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.05E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
The United States of America, as represented by the Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.07E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
